Pfizer/BioNTech jab safe for children aged five to 11
The positive trial results could pave the way for vaccinating children younger than 12, if approved.
Follow Our Network On LinkedIn: Follow link
The positive trial results could pave the way for vaccinating children younger than 12, if approved.
